Alkermes (ALKS) PT Lowered to $44 at RBC Capital

April 7, 2026 9:05 AM

RBC Capital analyst Leonid Timashev lowered the price target on Alkermes (NASDAQ: ALKS) to $44.00 (from $45.00) while maintaining a rating.

No results found